1-(p-Tolyl)quinazolin-4(1H)-one94064-24-1,Purity95+%

Home>Supplier>ARK PHARM INC>1-(p-Tolyl)quinazolin-4(1H)-one

ARK PHARM INC

: Certified Store

: Reagent Business

: United States Illinois Chicago

: sales@arkpharminc.com

: 847-367-3680

Hot Search

trans-2-Butenoic acid

CAS NO.: 107-93-7

Purity :98%

4-methyl-2-nitrobenzoic acid

CAS NO.: 27329-27-7

Purity :97%

4-Hydroxybenzoic acid

CAS NO.: 99-96-7

Purity :98%

p-Toluic acid

CAS NO.: 99-94-5

Purity :95+%

Methyl 2-bromo-6-methoxybenzoate

CAS NO.: 31786-46-6

Purity :95+%

Catalog No. : AK152966

1-(p-Tolyl)quinazolin-4(1H)-one

CAS No : 94064-24-1
Packing : 1g
Brand :
Purity : 95+%
Loading Port :
Lead Time : 28Day (s)

Packing :

Price :: US $480.00 /1g MOQ 1g

Product Details & Description

Product Info

Compound	4(1H)-Quinazolinone, 1-(4-methylphenyl)-
CAS No.	94064-24-1	Catalog No.	AK152966	Brand
Purity	95+%	Packing	1g	Grade
Lead Time	28Day (s)	Origin		Loading Port

PropertiesMore

Boiling Point	420.3±38.0 °C (760 mmHg)
Density	1.17±0.1 g/cm3 (20 °C, 760 mmHg)
Melting Point	160-178 °C

Request For Quotation

Product: 1-(p-Tolyl)quinazolin-4(1H)-one

Cas No: 94064-24-1

*Purity

*Quantity

*Valid for

*Shipping To

Contact Person

*Email

*Company/Institute

Notes

I would like to have suppliers recommended by MOLBASE.

I agree to share my contact information to the supplier(s).

Related Products

2-(4-bromophenyl)chromen-4-one

CAS No : 20525-20-6
3-(3-aminophenyl)chromen-2-one

CAS No : 292644-31-6
4-hydroxy-3-phenyl-1H-1,8-naphthyridin-2-one

CAS No : 67862-28-6
4-hydroxy-3-phenyl-1H-1,5-naphthyridin-2-one

CAS No : 181122-95-2
2-(4-hydroxyphenyl)isoquinolin-1-one

CAS No : 20434-92-8
(4-METHYLPHENYL)-1-(2H)-PHTHALAZINONE

CAS No : 51334-85-1
flavonol

CAS No : 577-85-5
6-fluoro-2-phenylchromen-4-one

CAS No : 1218-82-2

Chemical Product Chemical Encyclopedia Structure CAS Number Search

Compound Synonyms: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9

Home Partners Business Cooperation Suppliers About Us Contact Us Privacy Policy Terms & Conditions Disclaimer